12,952 Intuitive Surgical, Inc. $ISRG Shares Acquired by ProShare Advisors LLC

Key Points

• ProShare Advisors increased its Intuitive Surgical stake by 3.4%, acquiring 12,952 shares to hold 398,808 shares worth approximately $162.2 million. Institutional investors collectively own 83.64% of the company.
• Analyst sentiment remains favorable, with a consensus rating of “Moderate Buy” and an average price target of $493.54, although recent targets and ratings were mixed.
• Intuitive Surgical reported strong quarterly results, with revenue up 21.7% year over year to $3.05 billion and EPS of $3.00 versus the $2.65 consensus estimate. The stock opened at $432.01 after declining 3.7%.

ProShare Advisors LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 398,808 shares of the medical equipment provider's stock after acquiring an additional 12,952 shares during the period. ProShare Advisors LLC owned about 0.12% of Intuitive Surgical worth $162,167,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Vise Technologies Inc. lifted its stake in shares of Intuitive Surgical by 43.7% in the 3rd quarter. Vise Technologies Inc. now owns 20,025 shares of the medical equipment provider's stock valued at $8,143,000 after purchasing an additional 6,087 shares during the period. Investment Partners LTD. boosted its position in shares of Intuitive Surgical by 105.9% in the 3rd quarter. Investment Partners LTD. now owns 2,854 shares of the medical equipment provider's stock worth $1,161,000 after purchasing an additional 1,468 shares in the last quarter. Cidel Asset Management Inc. acquired a new stake in Intuitive Surgical during the 3rd quarter worth about $216,000. Summit Global Investments boosted its holdings in Intuitive Surgical by 80.4% in the 3rd quarter. Summit Global Investments now owns 2,156 shares of the medical equipment provider's stock worth $877,000 after buying an additional 961 shares during the last quarter. Finally, Invera Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 40.5% in the third quarter. Invera Wealth Advisors LLC now owns 1,127 shares of the medical equipment provider's stock valued at $458,000 after purchasing an additional 325 shares during the period. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig Barratt sold 1,150 shares of the company's stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $510,370.00. Following the completion of the transaction, the director owned 1,150 shares in the company, valued at approximately $510,370. This represents a 50.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 20,095 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total value of $9,075,102.95. Following the transaction, the director owned 1,204,530 shares of the company's stock, valued at $543,977,793.30. This represents a 1.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 38,778 shares of company stock worth $16,814,967. 0.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on ISRG shares. Zacks Research raised shares of Intuitive Surgical from a "hold" rating to a "strong-buy" rating in a report on Thursday, October 22nd. Mizuho dropped their price objective on shares of Intuitive Surgical from $415.00 to $400.00 and set a "neutral" rating on the stock in a report on Wednesday, October 21st. Leerink Partners set a $503.00 price target on shares of Intuitive Surgical and gave the company an "outperform" rating in a report on Wednesday, October 21st. HSBC downgraded Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. Finally, UBS Group reiterated a "buy" rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. One analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $493.54.

Intuitive Surgical Trading Down 3.7%

ISRG opened at $432.01 on Friday. The stock has a market capitalization of $149.75 billion, a P/E ratio of 52.24, a PEG ratio of 2.98 and a beta of 1.46. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The stock has a 50-day moving average price of $401.54 and a 200-day moving average price of $434.05.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business had revenue of $3.05 billion for the quarter, compared to analysts' expectations of $2.91 billion. During the same quarter last year, the company posted $2.40 EPS. The company's revenue was up 21.7% compared to the same quarter last year. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.